Related Experiment Video

Updated: May 5, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K

New developments in the anti-neoplastic drug management of ovarian cancer

Maurie Markman1

  • 1Cancer Treatment Centers of America, Eastern Regional Medical Center 1331 East Wyoming Avenue, Philadelphia, PA 19124 USA.

F1000Prime Reports
|November 26, 2013
PubMed

Insights

Recent ovarian cancer trials offer new management strategies and improved patient outcomes. This review examines key evidence-based randomized trials impacting standard care for this malignancy.

Area of Science:

  • Gynecologic Oncology
  • Clinical Trials
  • Evidence-Based Medicine

Background:

  • Ovarian cancer management has seen significant advancements.
  • Randomized trials are crucial for updating treatment protocols.

Purpose of the Study:

  • To review recent evidence-based randomized trials in ovarian cancer.
  • To discuss the potential impact on standard management and patient outcomes.

Main Methods:

  • Review of key randomized controlled trials.
  • Analysis of trial data relevant to ovarian cancer treatment.

Main Results:

  • Identification of trials with potential to alter standard ovarian cancer care.
  • Summary of findings that may enhance patient outcomes.

Conclusions:

  • Recent trials provide critical data for evolving ovarian cancer treatment.
  • The reviewed evidence supports a shift in management paradigms for improved clinical results.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

10.4K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K